StockRing: 11/15/09, (NYSE:AGN), $59.63, "SUPER BUY" ALLERGAN INC (AGN) Stock on Sunday, November 15, 2009

Login    About Us    Our Blog    Our Twitter    Contact Us     11/15/09, (NYSE:AGN), $59.63, "SUPER BUY" ALLERGAN INC (AGN) Stock  AGN opened at $59.24 and it is $+0.16, (+0.27%). Today's trading range is $59.1656 - 59.92. 1y target price is $65.04.  DOW     +0.72%    +73.00    10270.47           ENGLAND     +0.38%    +19.88    5296.38           JAPAN     -0.35%    -34.18    9770.31  NASDAQ     +0.88%    +18.86    2167.88           GERMANY     +0.40%    +22.87    5686.83           CHINA     +0.46%    +14.7    3187.647  S&P 500     +0.57%    +6.24    1093.48           FRANCE     -0.05%    -2.06    3806.01           INDIA     +0.92%    +152.8    16848.83  CANADA     +0.41%    +46.92    11407.68           ITALY     -1.09%    -174.00    15743.00           RUSSIA     -0.41%    -5.85    1419.49  MEXICO     +0.79%    +242.24    31002.090           SWISS     -0.07%    -4.68    6351.08           TAIWAN     -0.07%    -5.3    7665.63

Stocks Funds SYMBOL:    YouTube Our Blog 11/11/09 StockRing Urgent Advice: Buy stocks on 11/12/09 - expect gains this week !!!    Option Exp: SAMPLE ! Option Exp:    EUROs for $1 DOLLAR: 3 MONTHS       Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!! 1. Dow Jones Index - 30 Stocks on 11/12/2009:  Buy   93% or 28   Hold   7% or 2   Sell   0% or 0 stocks     2. World Markets - 72 Indexes on 11/11/2009:  Buy   63% or 44   Hold   21% or 15   Sell   16% or 11 indexes 3. Best Brands - 200 stocks on 11/12/2009:  Buy   76% or 152   Hold   17% or 33   Sell   7% or 14 stocks 4. Hot News - 200 stocks on 11/8/2009:  Buy   47% or 93   Hold   23% or 46   Sell   30% or 60 stocks 5. Big Movers - 200 stocks on 11/14/2009:  Buy   69% or 137   Hold   23% or 47   Sell   8% or 15 stocks 6. Top Hitters - 200 stocks on 11/11/2009:  Buy   77% or 153   Hold   15% or 31   Sell   8% or 15 stocks 7. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341   Hold   21% or 106   Sell   11% or 53 stocks 8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292   Hold   15% or 61   Sell   12% or 47 stocks 9. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   66% or 395   Hold   26% or 156   Sell   8% or 49 stocks 10. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81   Hold   35% or 56   Sell   16% or 27 stocks 11. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263   Hold   26% or 115   Sell   14% or 62 stocks 12. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109   Hold   6% or 12   Sell   33% or 59 stocks 13. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58   Hold   34% or 34   Sell   8% or 8 stocks 14. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133   Hold   51% or 176   Sell   11% or 37 funds 15. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84   Hold   46% or 73   Sell   2% or 4 funds 16. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19   Hold   50% or 47   Sell   30% or 28 stocks 17. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111   Hold   34% or 70   Sell   13% or 28 stocks                                              TOTAL RATINGS:   Buy   60% or 2493   Hold   27% or 1080   Sell   13% or 517 stocks Video: 6-24-09 - Dow 30 stocks Buy-Sell-Hold Ratings 11/15/2009  Sunday, November 15, 2009 (Irvine, California) Today StockRing.com Recommendation is to "SUPER BUY"for ALLERGAN INC (NYSE:AGN) Stock. AGN stock opening price was $59.24 per share. Current price of NYSE:AGN Stock is $59.63 per share and it is $+0.16, (+0.27%) today and it was trading in the daily range of $59.1656 - 59.92 per share. Current Bid Price for (NYSE:AGN) stock is $58.90 and the Ask Price is $60.56. In the last 52 weeks AGN stock was trading in the range of $28.95 - 60.85. 50-Day Moving Average for (NYSE:AGN) stock is $57.2587 and 200-Day Moving Average is $51.852. On average analysts predict that One Year Target Estimated price for (NYSE:AGN) stock is $65.04. ALLERGAN INC (NYSE:AGN) Market capitalization is $18.098B. (NYSE:AGN) stock average daily volume is 1,746,490 shares per day. However, on last trading session of Nov 13, 2009 AGN stock traded 928,843 shares. Also The Short Ratio for (NYSE:AGN) stock is 2.00. On previous trading session AGN Stock closed at $59.47 per share. Last year ALLERGAN INC (NYSE:AGN) before taxes (EBITDA) (ttm) earned $1.262B on total revenue of $4.336B. Earnings Per Share - EPS (ttm) for AGN stock is 1.842. Also, (NYSE:AGN) Stock Price Per Earnings ratio - P/E is 32.29. Thus, (NYSE:AGN) Stock Price/Sales (ttm) ratio is 4.16 and Price/Book (mrq) ratio is 3.97. (NYSE:AGN) Stock pays a dividend of $0.20 per share which is a yield of 0.34%. So at this time (NYSE:AGN) Stock maintains Trailing Annual Dividend Rate at 0.20 . StockRing Recommendations for ALLERGAN INC (NYSE:AGN) Stock are updated daily here http://www.StockRing.com/sr/StockDetail.asp?StockName=AGN If you would like to receive Buy-Sell-Hold ratings for over 50,000 stocks, mutual funds, and ETFs go to StockRing web site: http://www.StockRing.com. AGN Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max   News    Options!   More Info 11/15/2009 1 Year Stock market price chart for ALLERGAN INC (NYSE:AGN) Stock on Sunday, November 15, 2009    1 Year Dow Jones Chart 1 Year S&P 500 Chart 1 Year Nasdaq Chart 1 Year Canada Chart 11/15/2009 5 days Stock market price chart for ALLERGAN INC (NYSE:AGN) Stock on Sunday, November 15, 2009    5 Days Dow Jones Chart 5 Days S&P 500 Chart 5 Days Nasdaq Chart 5 Days Canada Chart AGN Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max   News    Options!   More Info 11/15/2009 Stock market price quote data for ALLERGAN INC (NYSE:AGN) Stock on Sunday, November 15, 2009 Last Trade: 59.63 Trade Time: Nov 13 Change: +0.16, (+0.27%) Prev Close: 59.47 Open: 59.24 Bid: 58.90 Ask: 60.56 1y Target Est: $65.04 50-Day Moving Average: 57.2587 200-Day Moving Average: 51.852 Short Ratio: 2.00 Trailing Annual Dividend Rate: 0.20 Day's Range: 59.1656 - 59.92 52wk Range: 28.95 - 60.85 Volume: 928,843 Avg Vol: 1,746,490 Market Cap: 18.098B P/E (ttm): 32.29 EPS (ttm): 1.842 Div & Yield: 0.20 (0.34%) Revenue (ttm): 4.336B Earnings before Tax (EBITDA) (ttm): 1.262B Price/Sales (ttm): 4.16 Price/Book (mrq): 3.97 Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!    EUROs for $1 DOLLAR: 3 MONTHS       ALLERGAN INC (NYSE: AGN) Company Information Allergan Inc. 2525 Dupont Drive Irvine, CA 92612 United States - Map Phone: 714-246-4500 Fax: 714-246-6987 Web Site: http://www.allergan.com ALLERGAN INC (NYSE: AGN) DETAILS ALLERGAN INC (NYSE: AGN) Index Membership: S&P 500 S&P 1500 Super Comp ALLERGAN INC (NYSE: AGN) Sector: Healthcare ALLERGAN INC (NYSE: AGN) Industry: Drug Manufacturers - Other ALLERGAN INC (NYSE: AGN) Full Time Employees: 8,000 ALLERGAN INC (NYSE: AGN) BUSINESS SUMMARY Allergan, Inc., a multi-specialty healthcare company, discovers, develops, and commercializes specialty pharmaceutical, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other specialty markets worldwide. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment offers a range of pharmaceutical products, including ophthalmic products for chronic dry eye, glaucoma therapy, ocular inflammation, infection, and allergy; Botox for the therapeutic and aesthetic indications; skin care products for acne, psoriasis, and other skin care products; eyelash growth products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery; obesity intervention products, including the Lap-Band System and the BIB BioEnterics Intragastric Balloon; and facial aesthetics products. The company also offers Contigen for the treatment of urinary incontinence due to intrinsic sphincter deficiency. It sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, and ambulatory surgery centers, as well as to medical practitioners, including ophthalmologists, neurologists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, pediatricians, urologists, and general practitioners. Allergan, Inc. has strategic research collaboration agreements with ExonHit Therapeutics S.A.; Spectrum Pharmaceuticals, Inc.; and Pieris. The company was founded in 1948 and is headquartered in Irvine, California. ALLERGAN INC (NYSE: AGN) KEY EXECUTIVES, SALARIES and BONUSES Mr. David E.I. Pyott , Age: 55 Chairman and Chief Exec. Officer Salary: $ 2.56M Bonus: $ 0 Mr. Michael Ball , Age: 51 Pres Salary: $ 1.01M Bonus: $ 0 Mr. Gavin S. Herbert , Age: 76 Founder, Chairman Emeritus and Member of Science & Technology Committee Salary: $ 57.00K Bonus: N/A Mr. Jeffrey L. Edwards , Age: 48 Chief Financial Officer and Exec. VP of Fin. & Bus. Devel. Salary: $ 759.00K Bonus: $ 0 Mr. Douglas S. Ingram J.D., Esq., Age: 46 Chief Admin. Officer, Chief Ethics Officer, Exec. VP, Gen. Counsel and Sec. Salary: $ 828.00K Bonus: $ 521.00K 1. Dow Jones Index - 30 Stocks on 11/12/2009:  Buy   93% or 28   Hold   7% or 2   Sell   0% or 0 stocks     2. World Markets - 72 Indexes on 11/11/2009:  Buy   63% or 44   Hold   21% or 15   Sell   16% or 11 indexes 3. Best Brands - 200 stocks on 11/12/2009:  Buy   76% or 152   Hold   17% or 33   Sell   7% or 14 stocks 4. Hot News - 200 stocks on 11/8/2009:  Buy   47% or 93   Hold   23% or 46   Sell   30% or 60 stocks 5. Big Movers - 200 stocks on 11/14/2009:  Buy   69% or 137   Hold   23% or 47   Sell   8% or 15 stocks 6. Top Hitters - 200 stocks on 11/11/2009:  Buy   77% or 153   Hold   15% or 31   Sell   8% or 15 stocks 7. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341   Hold   21% or 106   Sell   11% or 53 stocks 8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292   Hold   15% or 61   Sell   12% or 47 stocks 9. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   66% or 395   Hold   26% or 156   Sell   8% or 49 stocks 10. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81   Hold   35% or 56   Sell   16% or 27 stocks 11. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263   Hold   26% or 115   Sell   14% or 62 stocks 12. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109   Hold   6% or 12   Sell   33% or 59 stocks 13. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58   Hold   34% or 34   Sell   8% or 8 stocks 14. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133   Hold   51% or 176   Sell   11% or 37 funds 15. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84   Hold   46% or 73   Sell   2% or 4 funds 16. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19   Hold   50% or 47   Sell   30% or 28 stocks 17. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111   Hold   34% or 70   Sell   13% or 28 stocks                                              TOTAL RATINGS:   Buy   60% or 2493   Hold   27% or 1080   Sell   13% or 517 stocks 11/15/2009 Latest stock market news data for ALLERGAN INC (NYSE:AGN) Stock on Sunday, November 15, 2009 Spectrum Pharmaceuticals and Nippon Kayaku Collaborate to Develop Apaziquone in Asia Trading Markets - Nov 14, 2009 Nov 13, 2009 (Close-Up Media via COMTEX) -- SPPI -- Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, and Nippon Kayaku announced an ... Spectrum Pharmaceuticals Announces Third Quarter 2009 Corporate Update; ZEVALIN ® Sales up 80% over Third Quarter 2008 dBusinessNews San Jose - Nov 12, 2009 IRVINE, Calif.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial-stage biotechnology company with a primary focus in oncology, today reported financial results for ... New Report Just Published Allergan Inc - Detailed Product Pipeline Live-PR.com - Nov 11, 2009 (live-PR.com) - Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue. contain detailed information on pipelines by ... Allergan (AGN) NewsBite - AGN Hits 52-Week High Market Intelligence Center - Nov 10, 2009 Allergan (NYSE: AGN) hit a new 52-Week high of $60.25 so far today. Currently the stock is up $0.10 (0.16%) to $59.97 on 712,947 shares traded. Today's high is up $31.02 from a 52-Week Low of $28 ... Medicis, Allergan fight for wrinkle-fighting consumers FiercePharma - Nov 10, 2009 Cosmetic drugs are hot and happening even as the economy limps along--just take a gander at cosmeceuticals specialist Medici's latest numbers as proof. But not all beautifying treatments are ... MaxLinear Names AJ "Bert" Moyer to Board of Directors Trading Markets - Nov 10, 2009 CARLSBAD, CA, Nov 10, 2009 (MARKETWIRE via COMTEX) -- WDC -- MaxLinear Inc., a leading provider of radio-frequency (RF) & mixed-signal IC solutions for broadband communications applications, today ... Caraco Pharmaceutical Laboratories launches new eye drug Trading Markets - Nov 10, 2009 Nov 10, 2009 (Datamonitor via COMTEX) -- AGN -- Caraco Pharmaceutical Laboratories, a developer of generic and private-label pharmaceuticals, has launched ketorolac tromethamine ophthalmic ... Spectrum Pharmaceuticals and Nippon Kayaku Enter Collaboration Agreement for Apaziquone in Asian Territories Business Wire - Nov 10, 2009 IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial stage biotechnology company with a primary focus in oncology, and Nippon Kayaku today announced an ... Ozurdex (Allergan) Uses Billing Structure That May Prevent Acceptance Gerson Lehrman Group - Nov 10, 2009 Ozurdex (Allergan) is now on the market and available for ophthalmologists to treat patients with retinal vascular occlusions (RVO). While the technology and treatment may be sound, there may be ... Allergan Inc. (AGN) EVP, Fin & Bus. Dev., CFO Jeffrey L Edwards sells 32,592 Shares GuruFocus.com - Nov 9, 2009 EVP, Fin & Bus. Dev., CFO of Allergan Inc. (AGN) Jeffrey L Edwards sells 32,592 shares of AGN on 11/06/2009 at an average price of $59.27 a share. Allergan Inc. has a market cap of $18.02 billion ... Acciona, Anheuser-Busch, Galp, Repsol: European Equity Preview Bloomberg Aegon NV (AGN NA): The owner of US insurer Transamerica Corp. will report third-quarter results before stock trading starts. Aegon advanced 4.1 percent to ... ADR Report: ADRs Close Lower With Broad Sector Weakness Wall Street Journal BA) fell 7.8% to $7.85, Aegon NV (AEG, AGN.AE) slipped 7.6% to $7.51 and Orix Corp. (IX, 8591.TO) declined 5.5% to $34.54. The process industry also closed ... UPDATE 3-Allergan profit rises as Botox rebounds Reuters NEW YORK, Oct 29 (Reuters) - Allergan Inc (AGN.N) said quarterly profit rose 8 percent as sales of anti-wrinkle drug Botox rebounded and ... Allergan Q3 2009 Earnings Call TranscriptSeeking Alpha (blog) Allergan profit rises, Botox reboundsForbes Allergan Q3 Profit Rises; Lifts FY09 Adj. EPS Outlook - UpdateTrading Markets (press release) Reuters all 73 news articles » Crain's Chicago Business Akorn takes 3Q loss on weak vaccine revenue CNBC Akorn also took a $1.1 million charge as it wrote down the value of stock issued earlier this year. In total the company lost $5.1 million, or 6 cents per ... Akorn posts $5.1 million third-quarter net lossOSN SuperSite all 24 news articles » Market Report -- Short Stories (SPPI) MSN Money Briefing.com is the leading Internet provider of live market analysis for US Stock, US Bond, and world FX market participants. Spectrum Pharmaceuticals Has Risen Above Today's RangeTrading Markets (press release) Spectrum Pharmaceuticals To Develop Bladder Drug With Nippon KayakuWall Street Journal Spectrum (Nasdaq:SPPI) Continues Quiet, Steady ComebackSmall Cap Network all 26 news articles » About this author: Seeking Alpha (blog) Allergan (AGN) is expected to report Q3 earnings on Thursday, October 29 before the market open with a conference call scheduled for 11am ET. ... and more » ING to split banking and insurance operations MarketWatch ... depending on whether its stock price is above 11.16 euros. That premium of 12% to 19% is steeper than the 10% Aegon (AMSTERDAM:NL:AGN) was assessed. ... and more » "Market Monitor"-Eugene Peroni, Portfolio Manager for Advisors Asset Management Nightly Business Report PERONI: Allergan (AGN), symbol AGN, the company that makes Botox. Good earnings recently. This stock is holding up quite nicely. ... ADR Report: ADRs Close Lower; Banks Fall On ING Restructuring Wall Street Journal Other decliners included Dutch bank Aegon NV (AEG, AGN.AE), which slid 8% to $7.90; the UK's Lloyds Banking Group PLC (LYG, LLOY. ... and more » Earnings News : EXPE, NEM, FTE, FSLR, CVX, AEP, ODP, XRAY, MCO, ORLY, AGN, SII ... istockAnalyst.com (press release) Our pro forma estimate excludes restructuring expenses, deferred stock compensation and intangibles amortization charges in the last quarter. ... and more » 11/15/2009 News from StockRing Blog about ALLERGAN INC (NYSE:AGN) Stock on Sunday, November 15, 2009 12/7/2008 StockRing advise: SELL 33% or 163, HOLD 47% or 237, BUY ... AGN, BUY - Allergan, Inc. (NYSE : AGN), Dec 5, 38.54, +2.12, +5.82%, 2877487. 20. AIG, HOLD - American International Group... (NYSE : AIG), Dec 5, 1.94, +0.10, +5.43%, 57956796. 21. AIV, SUPER SELL - Apartment Investment and. ... 12/7/2008 stockring advise: sell 33% or 163, hold 47% or 237, buy ... agn, buy - allergan, inc. (nyse : agn), dec 5, 38.54, +2.12, +5.82%, 2877487. 20. aig, hold - american international group... (nyse : aig), dec 5, 1.94, +0.10, +5.43%, 57956796. 21. aiv, super sell - apartment investment and. ... 12/25/2008 stockring advise: sell 35% or 176, hold 39% or 195, buy ... agn, hold - allergan, inc. (nyse : agn), dec 24, 36.44, +0.28, +0.77%, 380869. 20. aig, hold - american international group... (nyse : aig), dec 24, 1.56, +0.01, +0.65%, 12441717. 21. aiv, hold - apartment investment and. ... 12/3/2008 stockring advise: sell 39.4% or 197, hold 50.4% or 252 ... agn, hold - allergan, inc. (nyse : agn), 4:06pm, 36.20, +1.39, +3.99%, 2520686. 20. aig, hold - american international group... (nyse : aig), 4:02pm, 2.01, +0.14, +7.49%, 96811632. 21. aiv, super sell - apartment investment and. ... 11/22/2008 stockring buy-sell-hold ratings for s&p 500 stocks agn, sell - allergan, inc. (nyse : agn), nov 20, 29.65, -4.46, -13.08%, 4701486. 20. aig, sell - american international group... (nyse : aig), nov 20, 1.44, -0.12, -7.69%, 84735864. 21. aiv, super sell - apartment investment and. ... 12/7/2008 stockring advise: sell 33% or 163, hold 47% or 237, buy ... agn, buy - allergan, inc. (nyse : agn), dec 5, 38.54, +2.12, +5.82%, 2877487. 20. aig, hold - american international group... (nyse : aig), dec 5, 1.94, +0.10, +5.43%, 57956796. 21. aiv, super sell - apartment investment and. ... 12/7/2008 stockring advise: sell 33% or 163, hold 47% or 237, buy ... agn, buy - allergan, inc. (nyse : agn), dec 5, 38.54, +2.12, +5.82%, 2877487. 20. aig, hold - american international group... (nyse : aig), dec 5, 1.94, +0.10, +5.43%, 57956796. 21. aiv, super sell - apartment investment and. ... 12/3/2008 stockring advise: sell 39.4% or 197, hold 50.4% or 252 ... agn, hold - allergan, inc. (nyse : agn), dec 3, 36.20, +1.39, +3.99%, 2520686. 20. aig, hold - american international group... (nyse : aig), dec 3, 2.01, +0.14, +7.49%, 96811632. 21. aiv, super sell - apartment investment and. ...    Abele John   Abrams George    Abrams Jonathan   Ackermann Josef   ACUSHNET   A.I.G.   AIG   Albright Madeleine   AMAZON.COM   AMERITRADE   Andelman David   Andreessen Marc   Angwin Julia   Anthony Jim   APAX PARTNERS   ARCH VENTURE PARTNERS   ARONSSON GROUP   Ashworth Paul   AT&T   AVON BOOKS   Bair Sheila   BANK OF AMERICA   BARCLAYS   Barton Rich   Bassett Angela   BEAR STEARNS   Begich Mark   Bell Bryon   Bennett Tony   Berke Barry   Bernanke Ben   BET   BETSEY JOHNSON   Biaggi Mario   Bierut Michael   Biondi Frank   Blankfein Lloyd   Blinder Alan   Bock Jeff   BOEING   Boncompagni Tatiana   Bond Adam   Bond Victoria   Born Brooksley   BOSTON SCIENTIFIC   BP   Brazinski Daniel   Breslin Jimmy   Brody Kenneth   Brown Greg   Burkle Ron   Burow Kristina   Burrough Bryan   Bush George W.   Callan Erin   CALLAWAY GOLF   CARLYLE GROUP    CASCADE INVESTMENT   Cassano Joseph   Dauman Philippe   De Niro Robert   Dickerson Paul   Dillon Harrison   DISNEY   Dodd Christopher   Donaldson William   Douglas Michael   Draghi Mario   DREAMWORKS SKG   DUTTON   Dykstra Lenny   Eisner Michael   ELECTRONIC ARTS   Emanuel Rahm   ENRON   ESL INVESTMENTS   Evans Robert   Falcone Philip   FANNIE MAE   FEDERATED DEPARTMENT   STORES   FINANCO   Flavin Jennifer   Fleckenstein Bill   Foreman George   Frank Barney   Frears Stephen   FREDDIE MAC   Freston Tom   Friedman Stephen   Fuld Dick   Furman Roy   Garavani Valentino   Gates Bill   Geffen David   Geithner Tim   GENERAL MOTORS   Gensler Gary   Gerdeman Fred   Gibson Charles   GLASSDOOR   GLG PARTNERS   GOLDMAN SACHS   Greenspan Alan   Greenspan Glenn   Grey Brad   Griffin Kathy   Griffin Ken   Grove Andy   HALSTON   HARBINGER CAPITAL   PARTNERS   Harrison Gilbert   Harrison Mya   HCR MANORCARE   HEWLETT-PACKARD   HILCO CONSUMER   CAPITAL   Hohman Robert   JEFFRIES & CO.   Jobs Steve   Johnson Magic   Johnson Robert   Jolie Angelina   Jordan Michael   JP MORGAN CHASE   Kaczynski Ted   Karan Donna   Kargman Jill   Karmazin Mel   Kashkari Neel   King Larry   Knowles Beyonce   KohlbergJerry   KopelmanArie   KopelsonAnne   KopelsonArnold   Korff Ira   Korff Kimberlee   Kurzman David   Lagrange Pierre   Lampert Eddie   Lansing Sherry   LEHMAN BROTHERS   LENDINGTREE   Levitt Arthur   Levy Leon   Liddy Ed   LINKEDIN   Little Edward   Loeb Allan   Lois George   LONG-TERM CAPITAL   MANAGEMENT   Lonski John   Lundgren Terry   MACYS   Madoff Bernie   Marcus Bernie   Marriott Bill   Maskin Eric   Mason Richard   MATTHEW WILLIAMSON   MAY DEPARTMENT   STORES   McCombs Red   McKinnon Mark   McLucas William   Meltzer Allan   MERRILL LYNCH   MGM   MICROSOFT   MIDWAY GAMES   Misner Jeff   Mitchell Andrea   Moglia Joe   Molinaro Sam   MOODYS INVESTORS   SERVICE   Moonves Leslie   Morgan Peter   MORGAN STANLEY   Moses Herb   MOTOROLA   Mozilo Angelo   Murdoch Rupert   Murphy Eddie   MYSPACE   Nader Ralph   Nardelli Bob   NATIONAL AMUSEMENTS   NEWS CORP.   Nicholas Pete   Nicklaus Tack   NICKLAUS DESIGN   NIKE   Norquist Grover   NRDC EQUITY PARTNERS   Obama Barack   ODYSSEY PARTNERS   Oman Brady   OPPENHEIMER & CO.   OReilly Bill   OReilly Tim   OVERTURE FILMS   Paese Michael   Palin Sarah   PALM   Pandit Vikram   PARAMOUNT PICTURES   Partnoy Frank   Pataki George   Paulson Henry   Paulson John   Preston Kelly   Purcell Philip   Pyle Jason   RBS GREENWICH CAPITAL   Reardon Roy   Redstone Brent   Redstone Eddie   Redstone Michael   Redstone Paula   Redstone Phyllis   Redstone Shari   Redstone Sumner   RELIANCE   RENAISSANCE TECHNOLOGIES   ROYAL DUTCH SHELL   Rubin Robert   SAC CAPITAL ADVISORS   SALTON   SAPPHIRE ENERGY   Schiff Stephen   Schrager Ian   Schumer Chuck   Schwartz Alan   Scott Lee   Shields Brooke   SHUTTERFLY   SIEMENS   Silverman Ben   Simons James   SIX APART   SOCIALIZR   SOLAZYME   Sorkin Aaron   Sorkin Andrew Ross   Soros George   Spielberg Steven   Spurlock Morgan   Stallone Sylvester   Stanley Stephen   Staubach Roger   Steel Robert   Steinberg Mark   Stern Andy   Stiglitz Joseph   ST. MARTINS PRESS   Stone Oliver   Sullivan Mark T.   Summers Lawrence   SUTTER HILL VENTURES   TACONIC CAPITAL PARTNERS   DESIGN TOMMY HILFIGER   Travolta John   Trump Ivanka   TSM CAPITAL   CENTURY FOX   AFRIKA   TYCO   UBS   UNITED ARTISTS   UNIVERSAL   VALENTINO FASHION   GROUP   VANTAGE   V AUSTRALIA   VENROCK ASSOCIATES   VIA COM   Volcker Paul   VONAGE   WACHOVIA   Wagner Paula   Wales Jimmy   Wallison Peter   WAL-MART   WarinJoseph   WARNER BROTHERS   WASHINGTON MUTUAL   Waters Maxine   Waxman Henry   Weinstein Bob   Weinstein Harvey   WEINSTEIN CO.   Weiser Stanley   Welch Jack   Welling Beau   Whitacre Ed   White Kevin   Whitehead John   Williams Brian   Wilson Victoria   WMS INDUSTRIES   Wolfson Jonathan    Copyright © 2009 StockRing.com. All rights reserved. Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.

Buy from S&P 500:
Akamai - AKAM
Amazon.com - AMZN
Big Lots - BIG


Sell from S&P 500:
Alcoa - AA
Autodesk - ADSK
Aflac - AFL


Buy from S&P 400 MidCap:
Carmax - KMX
99c Stores - NDN
Netflix - NFLX


Sell from S&P 400 MidCap:
Timken - TKR
Trinity - TRN
Aflac - AFL


Buy from S&P 600 SmallCap:
Coinstar - CSTR
Holly - HOC
Maximus - MMS


Sell from S&P 600 SmallCap:
Barnes - B
Cascade - CAE
Brightpoint - CELL


Buy from Nasdaq 100:
Baidu.com - BIDU
Verisign - VRSN
Yahoo - YHOO


Sell from Nasdaq 100:
Adobe - ADBE
Amgen - AMGN
Costco - COST


Buy from Nasdaq Telecom:
Adtran - ADTN
CalAmp - CAMP
KongZhong - KONG


Sell from Nasdaq Telecom:
iBasis - IBAS
Interphase - INPH
RCN Corp - RCNI


Buy from Nasdaq Biotech:
Eurand - EURX
Illumina - ILMN
Trimeris - TRMS


Sell from Nasdaq Biotech:
Antigenics - AGEN
Celera - CRA
Incyte - INCY


Buy from Nasdaq Computer:
eLoyalty - ELOY
LogicVision - LGVN
Macrovision - MVSN


Sell from Nasdaq Computer:
Amtech - ASYS
Bsquare - BSQR
Corel - CREL


Buy from Nasdaq Finance:
Elbit - EMITF
Chardan - CACA
Tree.com - TREE


Sell from Nasdaq Finance:
BancFirst - BANF
FirstMerit - FMER
Advanta - ADVNA